Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: December 14, 2005
Event: Creation of a direct financial obligation.
Key Financial Metrics
This filing reports a specific financing transaction rather than comprehensive financial performance metrics.
- Debt Obligation: Borrowed an additional $500 million.
- Facility Details: Drawdown against an existing $2.5 billion term loan facility.
- Entity: Borrowing executed through a wholly-owned subsidiary.
- Revenue/Profit/Cash Flow: The filing text does not provide a clear value for these metrics.
Material Changes
The material change reported is the increase in debt obligations on December 14, 2005. This action utilizes capacity within a previously established credit facility referenced in a prior Form 8-K filed on August 11, 2005.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference the discussion from Item 1.01 of the August 11, 2005 Form 8-K regarding the term loan facility.
Risks and Contingencies: No new risks or contingencies are explicitly detailed in this specific text beyond the assumption of the new debt obligation.
Unusual Items: None reported.
Investor Verification Checklist
- Verify the terms and interest rate of the $2.5 billion term loan facility referenced in the August 11, 2005 filing.
- Confirm the total outstanding debt balance following this $500 million drawdown.
- Review the Company's most recent quarterly or annual report for updated liquidity and leverage ratios.